OPKO Health, Inc. Available-for-sale Securities
OPKO Health, Inc. (OPK) had Available-for-sale Securities of $3.11 million as of 2017-09-30, per its 10-Q filed 2017-11-08.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2017-11-08
- 2017-09-30: Available-for-sale Securities $3.11M.
- 2017-06-30: Available-for-sale Securities $3.79M.
- 2017-03-31: Available-for-sale Securities $3.99M.
- 2016-12-31: Available-for-sale Securities $4.53M.
| Period end | Available-for-sale Securities | Available-for-sale Securities as first filed |
|---|---|---|
| 2017-09-30 | $3.11M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $3.79M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $3.99M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $4.53M 10-Q · filed 2017-11-08 | |
| 2016-09-30 | $5.77M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $5.31M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $7.21M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $3.62M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $8.70M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $13.79M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $14.22M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $5.76M 10-K · filed 2016-02-29 | $12.07M 10-K · filed 2015-02-27 |
| 2014-09-30 | $13.29M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $9.88M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $12.00M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $12.06M 10-K · filed 2015-02-27 | |
| 2013-09-30 | $31.45M 10-Q · filed 2013-11-12 | |
| 2012-12-31 | $12.15M 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |